These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9097204)

  • 1. Efficacy of methylphenidate in bulimia nervosa comorbid with attention-deficit hyperactivity disorder: a case report.
    Schweickert LA; Strober M; Moskowitz A
    Int J Eat Disord; 1997 Apr; 21(3):299-301. PubMed ID: 9097204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulant treatment of bulimia nervosa with and without attention-deficit disorder: three case reports.
    Drimmer EJ
    Nutrition; 2003 Jan; 19(1):76-7. PubMed ID: 12507648
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possible connection between eating disorders and ADHD. Bulimia can relieve ADHD symptoms, central nervous stimulants are of good help].
    Ersson G; Klanger AR; Wallsten T; Nilsson KW; Lindström L
    Lakartidningen; 2007 May 2-8; 104(18):1402-5. PubMed ID: 17550013
    [No Abstract]   [Full Text] [Related]  

  • 4. Bulimia nervosa and attention deficit hyperactivity disorder: a possible role for stimulant medication.
    Dukarm CP
    J Womens Health (Larchmt); 2005 May; 14(4):345-50. PubMed ID: 15916509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate for Comorbid Epilepsy and Attention-Deficit/Hyperactivity Disorder.
    Naguy A; Alrashidi F; Elsori D
    Am J Ther; 2019; 26(6):e718-e720. PubMed ID: 31567149
    [No Abstract]   [Full Text] [Related]  

  • 6. Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
    Jaworowski S; Benarroch F; Gross-Tsur V
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):365-70. PubMed ID: 16768644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of bulimia nervosa symptoms after psychostimulant initiation in patients with comorbid ADHD: five case reports.
    Keshen A; Ivanova I
    Eat Disord; 2013; 21(4):360-9. PubMed ID: 23767675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate treatment for bulimia nervosa associated with a cluster B personality disorder.
    Sokol MS; Gray NS; Goldstein A; Kaye WH
    Int J Eat Disord; 1999 Mar; 25(2):233-7. PubMed ID: 10065402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate in the treatment of an adolescent female with obsessive-compulsive disorder and attention deficit hyperactivity disorder: a case report.
    King J; Dowling N; Leow F
    Australas Psychiatry; 2017 Apr; 25(2):178-180. PubMed ID: 27683657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of methylphenidate on oppositional defiant disorder comorbid with attention deficit/hyperactivity disorder.
    Serra-Pinheiro MA; Mattos P; Souza I; Pastura G; Gomes F
    Arq Neuropsiquiatr; 2004 Jun; 62(2B):399-402. PubMed ID: 15273834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An adolescent with kleptomania and attention-deficit/hyperactivity disorder treated with methylphenidate.
    Hergüner S; Tanidir C
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):383-4. PubMed ID: 21823916
    [No Abstract]   [Full Text] [Related]  

  • 13. Megadose intranasal methylphenidate (ritalin) abuse in adult attention deficit hyperactivity disorder.
    Coetzee M; Kaminer Y; Morales A
    Subst Abus; 2002 Sep; 23(3):165-9. PubMed ID: 12444349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of attention-deficit/hyperactivity disorder.
    Breggin PR
    JAMA; 1999 Apr; 281(16):1490-1; author reply 1491. PubMed ID: 10227316
    [No Abstract]   [Full Text] [Related]  

  • 15. Symptoms of Attention Deficit Hyperactivity Disorder (ADHD) among adult eating disorder patients.
    Svedlund NE; Norring C; Ginsberg Y; von Hausswolff-Juhlin Y
    BMC Psychiatry; 2017 Jan; 17(1):19. PubMed ID: 28095885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension.
    Ginsberg Y; Lindefors N
    Br J Psychiatry; 2012 Jan; 200(1):68-73. PubMed ID: 22075648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders.
    Skoglund C; Brandt L; D'Onofrio B; Larsson H; Franck J
    Eur Neuropsychopharmacol; 2017 Nov; 27(11):1144-1152. PubMed ID: 28935267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bulimia nervosa patient diagnosed with previously unsuspected ADHD in adulthood: clinical case report, literature review, and diagnostic challenges.
    Ioannidis K; Serfontein J; Müller U
    Int J Eat Disord; 2014 May; 47(4):431-6. PubMed ID: 24311027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate for attention-deficit/hyperactivity disorder: The longest debate.
    Levy F
    Aust N Z J Psychiatry; 2016 Jul; 50(7):616-7. PubMed ID: 27066820
    [No Abstract]   [Full Text] [Related]  

  • 20. [Attention deficit disorder: treatment with methylphenidate].
    Guerreiro MM; Montenegro MA; Piva RT; Moura-Ribeiro MV
    Arq Neuropsiquiatr; 1996 Mar; 54(1):25-9. PubMed ID: 8736140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.